Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

The investigational oral pre-exposure prophylaxis (PrEP) agent MK-8527 showed a similar, well-tolerated safety profile to ...

The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...

Experts have proposed new treatment modes for older people with HIV. The new treatment does not cause the health-threatening ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

For more than two decades, the global community has united to fight the HIV pandemic, achieving remarkable progress. New HIV transmissions and AIDS-related deaths have dropped significantly, and ...

Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with ...

The International AIDS Society (IAS) on Sunday called on President Trump to increase funding for AIDS research, warning that his proposed spending cuts could cause deaths. IAS president Linda-Gail ...